Company Encyclopedia
View More
name
CHISON MEDICAL
688358.SH
Chison Medical Technologies Co., Ltd. develops, manufactures, and sells diagnostic ultrasound systems in China and internationally. Its products include cart-based, portable, handheld, and B&W ultrasound systems for use in radiology, cardiovascular, women’s health, general imaging, SonoAi, point-of-care, and primary care fields. The company was founded in 1996 and is based in Wuxi, China.
932.45 B
688358.SHMarket value -Rank by Market Cap -/-

Financial Score

07/11/2025 Update
C
Health Care EquipmentIndustry
Industry Ranking46/63
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE9.80%B
    • Profit Margin30.25%A
    • Gross Margin60.34%A
  • Growth ScoreC
    • Revenue YoY1.20%C
    • Net Profit YoY31.47%B
    • Total Assets YoY-0.59%D
    • Net Assets YoY1.77%C
  • Cash ScoreC
    • Cash Flow Margin330.56%C
    • OCF YoY1.20%C
  • Operating ScoreD
    • Turnover0.28D
  • Debt ScoreA
    • Gearing Ratio11.24%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    CHISON MEDICAL released its performance for the first three quarters, with a net profit attributable to the parent company of 93.9205 million yuan, a year-on-year decrease of 4.56%

    According to the Zhitong Finance APP, CHISON MEDICAL released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 343 million yuan, a year-on-year decrease of 5.27%. The net profit attributable to shareholders of the listed company was 93.9205 million yuan, a year-on-year decrease of 4.56%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 86.9666 million yuan, a year-on-year decrease of 2.69%

    Zhitong·
    SH
    688358
    -0.60%
    Zhitong·
    SH
    688358
    -0.60%

    CHISON MEDICAL: Net profit in the third quarter was 24.2241 million yuan, a year-on-year increase of 41.95%

    CHISON MEDICAL announced that its revenue for the third quarter was 107 million yuan, a year-on-year decrease of 6.68%; net profit was 24.2241 million yuan, a year-on-year increase of 41.95%. Revenue for the first three quarters was 343 million yuan, a year-on-year decrease of 5.27%; net profit was 93.9205 million yuan, a year-on-year decrease of 4.56%

    Zhitong·
    SH
    688358
    -0.60%
    Zhitong·
    SH
    688358
    -0.60%

    CHISON MEDICAL plans to launch a restricted stock incentive plan in 2025

    According to the Zhitong Finance APP, CHISON MEDICAL disclosed the draft of the 2025 Restricted Stock Incentive Plan, intending to grant 160,000 shares of restricted stock to the incentive recipients, accounting for approximately 0.14% of the company's total equity at the time of the announcement of the incentive plan draft. This grant is a one-time grant with no reserved rights. The total number of incentive recipients is 17, and the grant price is RMB 16.50 per share

    Zhitong·
    SH
    688358
    -0.60%
    Zhitong·
    SH
    688358
    -0.60%

    CHISON MEDICAL's three major shareholders' reduction plan has expired, and none of them have implemented the reduction

    CHISON MEDICAL announced that the shareholder reduction plan has expired, and the three shareholders, Xiangding Investment, Shanghai Yude, and Xiangpeng Investment, did not implement any reductions. Previously, the three shareholders planned to reduce their holdings by no more than 1.05%, 0.37%, and 0.30%, respectively. As of August 21, 2025, the shareholding ratios of the three shareholders were 4.20%, 1.50%, and 1.20%, respectively. The actual reduction situation was consistent with the plan, and the reduction plan was not terminated early

    Zhitong·
    SH
    688358
    -0.60%
    Zhitong·
    SH
    688358
    -0.60%

    CHISON MEDICAL's actual controller Mo Ruoli plans to reduce his holdings by no more than 3%

    According to the announcement from Zhitong Finance APP, CHISON MEDICAL announced that its actual controller, chairman, and senior management personnel Mo Ruoli plan to reduce their holdings of a total of no more than 3,363,700 shares, which is no more than 3.00% of CHISON MEDICAL's total share capital, through centralized bidding or block trading within three months after the disclosure date of this reduction plan announcement

    Zhitong·
    SH
    688358
    -0.60%
    Zhitong·
    SH
    688358
    -0.60%